Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
Daniel Friedman
2019
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment
Marika Premoli
2019
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote
2019
Comparative Evaluation of ZLT-L-007, and Pregabalin (Lyrica®) for Pain Reduction in Diabetic Neuropathy: A Phase I Proof of Concept (POC) Observational Study
Zelira Therapeutics LTD
2021
Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats.
María Ceprián
2019